The original intention of the compression and circulation of the base drug catalogue is difficult to receive practical results.

The main purpose of the country's implementation of the Essential Medicines List is to alleviate the problem of “difficult medical treatment and expensive medical treatment” for the people. Specific to the actual operation, it is one of the 15% increase in the price of medicines. Guo Fanli, a researcher in the pharmaceutical industry of CIC, pointed out that although The original intention of the circulation of the national compressed drugs is good, but I am afraid it is difficult to receive practical results.

Guo Fanli, a researcher in the pharmaceutical industry of China Investment Consulting, pointed out that since the drugs entering the essential drug list are all generic names, not only one manufacturer of a drug, but the policy requires a provincial-level unified bidding for drugs in the essential drug list. In this case, the competition generated during local tendering is basically the same as before.

Guo Fanli pointed out that once a pharmaceutical company wants to win the bid, it may spend a lot of public relations expenses and service fees. After entering the basic drug list, the medicines have a price reduction of about 25%, which is not a small problem for pharmaceutical companies. The pressure is so that the price reduction space that pharmaceutical companies can afford is even more limited, making it difficult to achieve practical results in the original circulation of the circulation.

Guo Fanli also pointed out that in fact, 25% of drug price reduction expectations have already made many drug companies entering the list of essential drugs uneasy. After all, the follow-up policies for the basic drug system have not yet been introduced. It is still unknown, except for these, provinces and cities. The list of essential medicines and supplementary catalogues as well as specific rules are unclear, and pharmaceutical companies are waiting for changes in the next national policy.

According to the “2009-2012 China Pharmaceutical Industry Investment Analysis and Prospect Forecast Report” issued by China Investment Consultant, the basic drug list wants to reduce the cost of drugs in circulation to a large extent, but the original profit is good. In the case of damage, the pharmaceutical company needs to "change the price", or insist on the price needs to make a choice, but the original intention may not be effective.

Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 6cm×8cm 4pieces/box
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application]
For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for strains, sprains, cramp, bruises, swollen areas or joint stiffness.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions]
 Store below 30c in a dry place away from heat and direct sunlight.







Pain Relief Patch(Pain Areas)

Pain Relief Patch(Pain Areas),Shouler Pain Relief Patch,Joints Pain Relief Patch, Muscle Pain Relief Patch

Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xjplaster.com